TOLECTIN Drug Patent Profile

✉ Email this page to a colleague

When do Tolectin patents expire, and when can generic versions of Tolectin launch?

Tolectin is a drug marketed by Ortho Mcneil Janssen and is included in two NDAs.

The generic ingredient in TOLECTIN is tolmetin sodium. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tolmetin sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tolectin

A generic version of TOLECTIN was approved as tolmetin sodium by RISING on May 27^th, 1993.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for TOLECTIN?
What are the global sales for TOLECTIN?
What is Average Wholesale Price for TOLECTIN?

Summary for TOLECTIN

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	97
Patent Applications:	4,597
DailyMed Link:	TOLECTIN at DailyMed

Drug patent expirations by year for TOLECTIN

US Patents and Regulatory Information for TOLECTIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ortho Mcneil Janssen	TOLECTIN	tolmetin sodium	TABLET;ORAL	017628-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ortho Mcneil Janssen	TOLECTIN 600	tolmetin sodium	TABLET;ORAL	017628-002	Mar 8, 1989		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ortho Mcneil Janssen	TOLECTIN DS	tolmetin sodium	CAPSULE;ORAL	018084-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TOLECTIN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ortho Mcneil Janssen	TOLECTIN	tolmetin sodium	TABLET;ORAL	017628-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for TOLECTIN

See the table below for patents covering TOLECTIN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Spain	387542		⤷ Sign Up
Germany	2102746		⤷ Sign Up
Canada	924728	PROCESS FOR PREPARING AROYL-SUBSTITUTED PYRROLES AND PRODUCT PREPARED THEREBY	⤷ Sign Up
Switzerland	566984		⤷ Sign Up
Austria	313268		⤷ Sign Up
Japan	S55162767	MANUFACTURE OF 1*44DIALKYLL33ALKOXYCARBONYLPYRROLEE22ACETIC ACID ALKYLESTER	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for TOLECTIN

Make Better Decisions: Try a trial or see plans & pricing